Live Breaking News & Updates on Elarekibep Phase

Stay updated with breaking news from Elarekibep phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) Q1 2023 Earnings Call Transcript

Operator: Good day, ladies and gentlemen. And welcome to the Pieris Pharmaceuticals to host First Quarter 2023 Investor Call. ....

United States , Thomas Bures , Steve Yoder , Jonathan Miller , Hitto Kaufmann , Matt Phillips , Tom Bures , William Blair , Stephen Yoder , Shane Olwill , Pieris Anticalin , International Conference , Boston Pharmaceuticals , Pieris Pharmaceuticals , Health Photo , Pieris Pharmaceuticals Inc , European Respiratory Society , Call Transcript May , First Quarter , Chief Scientific Officer , Chief Development Officer , Investor Relations , Elarekibep Phase ,

Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) Q4 2022 Earnings Call Transcript

Operator: Hello and welcome to the Pieris Pharmaceuticals, Inc. Year-End 2022 Conference Call and Webcast. . A question-and-answer session will follow the formal presentation. ....

United States , Mary Fitzgerald , Thomas Bures , Shane Olwill , Stephen Yoder , Hitto Kaufmann , Steve Yoder , Tom Bures , Health Photo , Pieris Pharmaceuticals Inc , Bavarian Ministry Of Economic Affairs , Regional Development , Boston Pharmaceuticals , National Cancer Institute On Unsplash , Pieris Pharmaceuticals , Call Transcript March , Chief Scientific Officer , Chief Development Officer , Vice President , Project Leader Elarekibep , Investor Relations , Elarekibep Phase , National Cancer Institute , Bavarian Ministry , Economic Affairs , Owned Companies ,